Literature DB >> 26112216

Co-regulation of SREBP-1 and mTOR ameliorates lipid accumulation in kidney of diabetic mice.

Hui Wang1, Lin Zhu2, Jun Hao3, Huijun Duan1, Shuxia Liu1, Song Zhao1, Qingjuan Liu1, Wei Liu1.   

Abstract

SREBP-1 and mTOR have been proved to involve in renal lipid metabolism of diabetes mellitus. In the present study, we investigated the effect of co-regulation of SREBP-1 and mTOR on renal lipid metabolism using diabetic mice and cultured renal tubular cells. The results showed that compared with those in high glucose-stimulated HKC cells single transfected with shRNA-SREBP-1 vector, the level of SREBP-1 protein were significantly reduced by 64.1% followed by decreased FASN mRNA, ACC mRNA, ADRP protein and lipid droplets in HKC cells co-transfected with shRNA-SREBP-1 vector and kinase-dead mTOR vector. Furthermore, diabetic mice co-injected with shRNA-SREBP-1 vector and kinase-dead mTOR vector showed that renal SREBP-1 protein, FASN mRNA and ACC mRNA were respectively decreased by 34.6%, 45.9%, 22.0% in comparison with those in diabetic mice single injected with shRNA-SREBP-1 vector accompanied by reduced ADRP protein and triglyceride content. In the end our study suggests that co-regulation of SREBP-1 and mTOR in kidney of diabetic mice is more effective in lowering renal lipogenesis than only regulation of SREBP-1.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetic mice; Lipid metabolism; MTOR; Renal tubular cells; SREBP-1

Mesh:

Substances:

Year:  2015        PMID: 26112216     DOI: 10.1016/j.yexcr.2015.06.006

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

Review 1.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

2.  Nifedipine Exacerbates Lipogenesis in the Kidney via KIM-1, CD36, and SREBP Upregulation: Implications from an Animal Model for Human Study.

Authors:  Yen-Chung Lin; Jhih-Cheng Wang; Mai-Szu Wu; Yuh-Feng Lin; Chang-Rong Chen; Chang-Yu Chen; Kuan-Chou Chen; Chiung-Chi Peng
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

3.  The Role of the Unfolded Protein Response on Renal Lipogenesis in C57BL/6 Mice.

Authors:  Elizabeth Figueroa-Juárez; Lilia G Noriega; Carlos Pérez-Monter; Gabriela Alemán; Rogelio Hernández-Pando; Ricardo Correa-Rotter; Victoria Ramírez; Armando R Tovar; Iván Torre-Villalvazo; Claudia Tovar-Palacio
Journal:  Biomolecules       Date:  2021-01-07

4.  Regulation of lipid droplet (LD) formation in hepatocytes via regulation of SREBP1c by non-coding RNAs.

Authors:  Shereen A El Sobky; Nourhan K Aboud; Nihal M El Assaly; Injie O Fawzy; Nada El-Ekiaby; Ahmed I Abdelaziz
Journal:  Front Med (Lausanne)       Date:  2022-09-20

5.  Sodium Glucose Co-Transporter 2 Inhibitor Ameliorates Autophagic Flux Impairment on Renal Proximal Tubular Cells in Obesity Mice.

Authors:  Kazuhiko Fukushima; Shinji Kitamura; Kenji Tsuji; Yizhen Sang; Jun Wada
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.